Resources
At Lynx Dx, we’re dedicated to providing providers and families the resources they need to navigate the complexities of prostate cancer. Here you’ll find news, press releases, blog articles, events, research, and other content to support a care journey.
Can You Prevent Prostate Cancer by Following a Healthy Diet?
Research has added clarity to the relationship between diet and prostate cancer, including the role of antioxidants, phytochemicals, fatty acids, and processed meats.
Lynx Dx Announces Medicare Coverage for MyProstateScore 2.0, Marking a Major Milestone in Prostate Cancer Risk Assessment
Lynx Dx is proud to announce that MyProstateScore 2.0 (MPS2) has been approved for coverage from Medicare.
Yes, Prostate Cancer May Affect Sexual Performance. No, It’s Not Necessarily Permanent.
Having a prostatectomy often affects a man’s libido and ability to get an erection, but recovery is possible through penile rehabilitation, medication or devices.
5 Common Questions About Prostate Cancer, Answered
Information regarding prostate cancer symptoms, treatment options and their side effects, prognosis and survival rate, and how to detect it early.
What is a Prostatectomy, and What Does it Mean for Men Who Have Them?
Learn about open and laparoscopic prostatectomies performed to treat prostate cancer, the risks and what to expect after surgery.
Understanding Your MPS2 Patient Risk Report
Learn how to best understand your MyProstateScore 2.0 (MPS2) test results and work with your doctor to determine your next steps.
Why You Want Your Medical Test to be Validated and Based on Peer-Reviewed Research
MyProstateScore 2.0 is a clinically validated prostate cancer test based on “peer reviewed” research. What do these terms mean for men with a high PSA?
Lynx Dx Wins Award as One of ’50 Companies to Watch’ by Michigan Celebrates Small Business
ANN ARBOR, Mich.– Lynx Dx, a leader in innovative diagnostic solutions, has been recognized as one of [...]
Peer-Reviewed Research Published in JAMA Oncology Validates the Efficacy of MPS2
New peer-reviewed research published in the Journal of the American Medical Association (JAMA) Oncology validates the [...]